Vysioneer announces data sharing agreement with Pfizer to augment oncology clinical trials with AI
As part of the deal, Vysioneer gains access to one of Pfizer's oncology clinical trial datasets to apply its machine learning techniques to facilitate the drug efficacy assessment process